These authors overexpressed N-terminal mutant β-catenin protein in SW480 human CRC cells, which partially abrogated the exisulind-induced decrease in cyclin D1 protein and partially protected the cells from exisulind-induced apoptosis (Li et al, 2002). This evidence concerns the gene CCND1 and colorectal carcinoma.